Dyadic International Inc
- Last sale
- Nov 12, 2026 · -3.95%
- Market cap
- $14.63M
- 40.09M shares
- Filings
- 542
Q3 2026−11.6% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
—
—
—Q3 2026N/M FY25 yoy
Q3 2026−29.0% FY25 yoy
- $14.63M
- —
- 4.7×
- —
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $3,090,345 | reported | |
| FY 2024 | 2024-12-31 | $3,495,389 | reported | |
| FY 2023 | 2023-12-31 | $2,898,806 | reported | |
| FY 2022 | 2022-12-31 | $2,930,303 | reported | |
| FY 2021 | 2021-12-31 | $2,403,831 | reported | |
| FY 2020 | 2020-12-31 | $1,601,921 | reported | |
| FY 2019 | 2019-12-31 | $1,681,076 | reported | |
| FY 2018 | 2018-12-31 | $1,295,451 | reported | |
| FY 2017 | 2017-12-31 | $758,420 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2019 | — | $0.00 | $0.00 | — | 27.36M sh | +2.4% | — |
| FY2018 | — | $2.30M | $2.30M | — | 26.71M sh | −5.7% | — |
| FY2017 | — | $6.22M | $6.22M | — | 28.33M sh | — | — |
Segments
Products
LineFY2025ShareChange
Grant$1.86M60%—
Research and Development$967.31K31%−39.7%
License$265.00K8.6%−86.0%
Research and Development———
Total$3.09M
Biological products, except diagnostic substances
Dyadic International Inc is the 73rd largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
ZEOXZeo ScientifiX, Inc.$5.2M12.5%106.2%$10.7MPRMEPrime Medicine, Inc.$4.6M55.3%4,342.4%$705.9MOCGNOcugen, Inc.$4.4M8.8%1,537.4%$296.3MCGONCG Oncology, Inc.$4.0M254.7%3,985.0%$6.8BCRSPCRISPR Therapeutics AG$3.5M90.6%16,569.8%$4.1BSRZNSurrozen, Inc.$3.5M67.4%6,960.8%$605.8M
DYAIDyadic International Inc (this company)$3.1M11.6%238.3%$13.3M
ALGSAligos Therapeutics, Inc.$2.2M39.5%1,106.7%$12.6MHUMAHumacyte, Inc.$2.0M—2,003.6%$165.5MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Dyadic International Inc · CIK 1213809 · Engraved from SEC EDGAR